Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer
To access this article, please choose from the options below
PII: S1368-7646(11)00061-6
doi:10.1016/j.drup.2011.08.002
© 2011 Elsevier Ltd. All rights reserved.
